 MONROVIA, Calif.--BUSINESS WIRE--Xencor, Inc. NASDAQ:XNCR, a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that company management will participate at two upcoming investor conferences: Piper Sandler 33rd Annual Virtual Healthcare Conference Presentation Available: Monday, November 22, 2021, 10:00 a.m. EST 7:00 a.m. PST Evercore ISI 4th Annual HealthconX Conference Pre 